Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Myristoylated-peptidyl-recombinant Human CD59

EU orphan designation number: EU/3/02/114
Active ingredient: Myristoylated-peptidyl-recombinant Human CD59
Indication: Treatment of paroxysmal nocturnal haemoglubinuria
Sponsor: Orexo AB
Virdings Allé 32 A, 754 50 Uppsala, Svërige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/09/2002 Orphan designation EMEA/OD/016/02 (2002)3402 of 11/09/2002
29/06/2007 Change of name and/or address of sponsor
30/09/2008 Transfer of orphan designation EMEA/OD/016/02/T/01 (2008)5594 of 26/09/2008
03/03/2009 Removal of orphan designation from Community Register